Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
MedPage Today1d
Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Knowridge11d
This type of drug may increase risk of Parkinson’s disease
The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...
Science Daily9d
Parkinson's Research News
2024 — Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer's disease and Parkinson's disease but studies on long-term treatments are lacking. A new study highlights ...
Becker's Hospital Review2d
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Medical Xpress1mon
Blood immune cells could hold key to showing disease progression in Parkinson's
Mitochondrial dysfunction has long been associated with Parkinson's disease and a potential biomarker ... when the team considered the different types of cells present in the blood.